Abstract
Methylation of the 5′-region of the calcitonin gene was investigated in bone marrow and peripheral blood cells of 27 healthy volunteers and 25 leukemic patients. In all patients suffering from various forms of myeloid and lymphoid leukemia, hypermethylation of CpG sequences was observed in this region of the calcitonin gene. Cytosine hypermethylation in the CpG sequence did not involve cytosines of adjacent CpNpG sequences (where N is any nucleoside). The 5′-region of the calcitonin gene lacked CpNpG methylation both in healthy controls and in leukemic patients; this apparently represents specific “non-alternative” type of CpG methylation in the extended DNA sequence. Methylation of the calcitonin gene was monitored in 18 leukemic patients during malignant progression and medical treatment. Hypermethylation of the calcitonin gene was not observed on long-term clinical hematological remission. In ten patients characterized by unstable (or incomplete) remission hypermethylation of the calcitonin gene persisted through the whole period of observation. In relapses, hypermethylation of the calcitonin gene appeared again and in six patients, this “molecular relapse” being registered 1-8 months before onset of clinical and laboratory signs of disease progression. The leukemia-specific hypermethylation of CpG sequences of the 5′-region of the calcitonin gene is a promising prognostic and diagnostic marker of leukemias and might be useful for monitoring of this disease.
Similar content being viewed by others
REFERENCES
Burtseva, N. N., Azizov, Yu. M., Itkin, V. Z., and Vanyushin, B. F. (1977) Biokhimiya, 42, 1690-1696.
Romanov, G. A., and Vanyushin, B. F. (1981) Biochim. Biophys. Acta, 653, 204-218.
Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J.-P. (1998) Adv. Cancer Res., 72, 141-196.
Lichtenstein, A. V., and Kisseljova, N. P. (2001) Biochemistry (Moscow), 66, 235-255.
Baylin, S. B., Hopper, J. W., de Bustros, A., Steenberg, P. H., Lips, C. M., and Nelkin, B. D. (1986) Cancer Res., 46, 2917-2922.
Baylin, S. B., Fearon, E. R., Vogelstein, B., de Bustros, A., Sharkis, S. J., Burke, P. J., Staal, S. P., and Nelkin, B. D. (1987) Blood, 70, 412-417.
Nelkin, B. D., Przepiorka, D., Burke, P. J., Thomas, E. D., and Baylin, S. B. (1991) Blood, 77, 2431-2434.
Malinen, T., Palotie, A., Pakkala, S., Peltonen, L., Ruutu, T., and Jansson, S.-E. (1991) Blood, 77, 2435-2440.
Ritter, M., de Kant, E., Huhn, D., and Neubauer, A. (1995) Leukemia, 9, 915-921.
Leegwater, P. A., Lambooy, L. H., de Abreu, R. A., Bokkerink, J. P., and van den Heuvel, L. P. (1997) Leukemia, 11, 971-978.
Thomas, X., Teillon, M. H., Belhabri, A., Rimokh, R., Fiere, D., Magaud, J. P., and Archimbaud, E. (1999) Hematol. Cell Ther., 41, 19-26.
Roman, J., Castillejo, J. A., Jimenez, A., Bornstein, R., Gonzalez, M. G., del Carmen Rodriguez, M., Barrios, M., Maldonado, J., and Torres, A. (2001) Br. J. Haematol., 113, 329-338.
Clark, S. J., Harrison, J., and Frommer, M. (1995) Nature Genet., 10, 20-27.
Toth, M., Müller, U., and Doerfler, W. (1990) J. Mol. Biol., 214, 673-683.
Tasheva, E. S., and Roufa, D. J. (1994) Mol. Cell. Biol., 14, 5636-5644.
Woodcock, D. M., Lawler, C. B., Linsenmeyer, M. E., Doherty, J. P., and Warren, W. D. (1997) J. Biol. Chem., 272, 7810-7816.
Marinitch, D. V., Vorobyev, I. A., Smolnikova, V. V., Holmes, J., Baban, D., Shevchuk, T. V., Buryanov, Ya. I., and Miroshnikov, A. I. (1999) Gematol. Transfuziol., 44, 7-10.
Marinitch, D. V., Uss, A. L., Smirnova, L. A., Vorobyev, I. A., Holmes, J., Sulimova, G. E., Shevchuk, T. V., and Buryanov, Ya. I. (2001) Vopr. Med. Khim., 47, 537-546.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual, 2nd Ed., Cold Spring Harbour Press, Cold Spring Harbour, N. Y.
Kosykh, V. G., Puntegis, S. A., Buryanov, Ya. I., and Baev, A. A. (1982) Biokhimiya, 47, 619-625.
Baryshev, M. M., Buryanov, Ya. I., Kosykh, V. G., and Baev, A. A. (1989) Biokhimiya, 54, 1894-1903.
Dhodapkar, M., Grill, J., and Lust, J. A. (1995) Leukemia Res., 19, 719-726.
Plass, C. (2002) Human Mol. Genet., 11, 2479-2488.
Palmisano, W. A., Divine, K. K., Saccomanno, G., Gilliland, F. D., Baylin, S. B., Herman, J. G., and Belinsky, S. A. (2000) Cancer Res., 60, 5954-5958.
Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B., and Nelson, W. G. (1994) Proc. Natl. Acad. Sci. USA, 91, 11733-11737.
Bird, A. P. (1986) Nature, 321, 209-213.
Broad, P. M., Symes, A. J., Thakker, R. V., and Craig, R. K. (1989) Nucleic Acids Res., 17, 6999-7011.
Buryanov, Ya. I., Shevchuk, T. V., Zakharchenko, N. S., Dyachenko, O. V., Marinitch, D. V., and Vorobyev, I. A. (2000) Bioorg. Khim., 26, 397-399.
Malone, C. S., Miner, M. D., Doerr, J. A., Jackson, J. P., Jacobsen, S. E., Wall, R., and Teitell, M. (2001) Proc. Natl. Acad. Sci. USA, 98, 10404-10409.
Lorincz, M. C., Schübeller, D., Goeke, S. C., Walters, M., Groudine, M., and Martin, D. I. (2000) Mol. Cell Biol., 20, 842-850.
Franchina, M., and Kay, P. H. (2000) DNA Cell Biol., 19, 521-526.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marinitch, D.V., Vorobyev, I.A., Holmes, J.A. et al. Hypermethylation of 5′-Region of the Human Calcitonin Gene in Leukemias: Structural Features and Diagnostic Significance. Biochemistry (Moscow) 69, 340–349 (2004). https://doi.org/10.1023/B:BIRY.0000022067.63532.b8
Issue Date:
DOI: https://doi.org/10.1023/B:BIRY.0000022067.63532.b8